亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

鹽酸大觀霉素

 
 
單價 面議對比
詢價 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
庫存 9999kg起訂1kg
型號 21736-83-4
過期 長期有效
更新 2021-07-28 09:12
 

武漢遠城嘉發(fā)膠原蛋白研究所

企業(yè)會員第15年
資料未認證
保證金未繳納
  • 湖北-武漢市
  • 上次登錄 2021-07-28
  • 陳經(jīng)理 (先生)   經(jīng)理
詳細說明
鹽酸大觀霉素                
產(chǎn)品名稱:鹽酸大觀霉素                
英文名稱:Spectinomycin Hydrochloride                
CAS 編號:21736-83-4                    
包裝規(guī)格:10十億單位/桶                     
規(guī)格型號:737u/mg 


產(chǎn)品說明: 
產(chǎn)品名稱:鹽酸大觀霉素
別名:奇霉素、壯觀霉素、淋必治、奇放線菌素、壯觀霉素、奇放素菌素鹽酸鹽
英文名:Spectinomycin Hydrochloride 
分子式:C14H26Cl2N2O7
分子量:405.27
CAS號:21736-83-4
質(zhì)量標準:CP2005/USP
鹽酸大觀霉素的性狀:本品為白色或類白色結(jié)晶性粉末。本品在水中易溶,在乙醇、氯仿或乙醚中幾乎不溶
pH值:3.8~5.6
水份:16.0~20.0%
比旋度:+15°~ +21°
熾灼殘渣:≤ 1.0
折干效價:≥737u/mg
鹽酸大觀霉素的用途: 本品為鏈霉菌所產(chǎn)生的一種氨基環(huán)醇類抗生素,是一新型特效專治淋病的抗生素,對淋病奈瑟菌有較強的抗菌作用
鹽酸大觀霉素包裝: 10十億單位/桶或25KG/桶
舉報收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
磷霉素 磷酸氯喹 磷酸泰樂菌素 硫氰酸鈉 氯菊酯 β-環(huán)狀糊精 β-紫羅蘭酮 阿苯達唑
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |